- bulk
Supplier Type
- contract manufacturer
- Manufacturer
- custom synthesis
- Reagent
- Trader
Supplier Region
- Hyderabad(25)
- Gujarat(113)
- Telangana(67)
- Maharashtra(164)
- New Delhi(19)
- Mumbai(22)
- Madhya Pradesh(12)
- Haryana(9)
- Kolkata(2)
- Uttar Pradesh(9)
- Kerela(1)
- Bangalore(4)
- Tamil Nadu(9)
- Karnataka(16)
- Himachal Pradesh(2)
- Rajasthan(4)
- Vadodara(2)
- AndhraPradesh(4)
- West Bengal(7)
- Punjab(6)
- GOA(1)
- Pune(1)
- Ahmedabad(3)
- Andhra Pradesh(2)
- NaviMumbai(1)
- Kerala(1)
Purity
- USP
- IP/BP/USP
- IP/BP/EP/USP
- IP / BP
- IH
- 99.55
- 99.50 %
- 99% Min
- 99%
- 98+
- 98%+
- 98%
- 96%
- 90 % Above
- 0.99
Package
- 0Metric Ton
- 0Std Packing
- 25mg
- 50mg
- 100mg
- 250mg
- 1gm
- 5gm
- 255025 to 50 kg
- 10gm
- 25gm
- 100gm
- 5kg
- 2550025kg and 500 kg
- 1kg
- 102510 Kg / 25 Kg
- 111kg or above 1kg needs enquiry
- 10kg
- 100500100mg or 500 mg
- 1 kg
- 5 kg
- 10 kg
- 25125kg and 1 MT
- 1grms kgs and MT
- 1grms to kgs
- 50010500 mg and 1.0 gm
- 20KG
- 25kg
- 50kg
- 100kg
- 500kg
- 1grms kgs amd MT
- 1MT
-
Hydroxypioglitazone
146062-44-4
-
5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide
1252927-47-1
-
67M-2
407582-47-2
-
67M-4
407582-49-4
-
BenzeneMethanol, a-[[[2-(4-aMinophenyl)ethyl]aMino]Methyl]-, (aR)-
391901-45-4
-
Mirabegron M5 (YM-538852)
1365244-63-8
-
Actarit
18699-02-0
-
67M-1
887945-96-2
-
RIP2 kinase inhibitor 1
1423186-80-4
-
5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one
150322-38-6
Pioglitazone metabolite MIV 146062-44-4
FEBUXOSTAT METABOLITE 67M-2 407582-47-2
GSK2983559 active metabolite 1423186-80-4
